Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Federal Trade Commission
Colorcon
Deloitte
QuintilesIMS
Accenture

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 7,824,907

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,824,907
Title:Expression vectors comprising the mCMV IE2 promoter
Abstract: The invention relates to an expression vector comprising the promoter of the mCMV-IE2 gene, or a functional expression promoting fragment thereof, and/or an enhancer of the mCMV-IE2 gene, or a functional expression enhancing fragment thereof, wherein expression vector does not contain any complete gene of the mCMV.
Inventor(s): Chatellard; Philippe (Lausanne, CH), Imhof; Markus (Chexbres, CH)
Assignee: Merck Serono SA (Coinsins, Vaud, CH)
Application Number:10/548,364
Patent Claims:see list of patent claims

Details for Patent 7,824,907

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Bayer Healthcare Pharms BETASERON interferon beta-1b VIAL; SUBCUTANEOUS 103471 001 1993-07-23   Try a Free Trial Merck Serono SA (Coinsins, Vaud, CH) 2023-03-11 RX Orphan search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17   Try a Free Trial Merck Serono SA (Coinsins, Vaud, CH) 2023-03-11 RX search
Serono Inc REBIF interferon beta-1a SYRINGE 103780 001 2002-03-07   Try a Free Trial Merck Serono SA (Coinsins, Vaud, CH) 2023-03-11 RX search
Serono Inc REBIF interferon beta-1a SYRINGE 103780 002 2002-03-07   Try a Free Trial Merck Serono SA (Coinsins, Vaud, CH) 2023-03-11 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Julphar
McKinsey
Queensland Health
Boehringer Ingelheim
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.